← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 4, 2020Last known activity
Jul 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05379322Lead sponsorPhase 3Jul 31, 2022
- NCT05379322Overall official - principal investigatorPhase 3Jul 31, 2022
- NCT05379322Study chairPhase 3Jul 31, 2022
- NCT04645485Lead sponsorPhase 1May 12, 2020
- NCT04473170Lead sponsorPhase 1/Phase 2Apr 4, 2020
- NCT04473170Overall official - principal investigatorPhase 1/Phase 2Apr 4, 2020
Details
- Last known activity
- Jul 31, 2022